Cargando…
New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis
Biologics targeting inflammation-related molecules in the immune system have been developed to treat rheumatoid arthritis (RA), and these RA treatments have provided revolutionary advances. Biologics may also be an effective treatment for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated va...
Autor principal: | Nozaki, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047311/ https://www.ncbi.nlm.nih.gov/pubmed/33868250 http://dx.doi.org/10.3389/fimmu.2021.631055 |
Ejemplares similares
-
Extracellular neutrophil traps: a novel therapeutic target in ANCA-associated vasculitis?
por: Diamantopoulos, Andreas P.
Publicado: (2013) -
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019) -
Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
por: O'Sullivan, Kim M., et al.
Publicado: (2021) -
Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020) -
Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)